From: Significance of CD133 expression in esophageal squamous cell carcinoma
 |  | Total (%) | CD133 expression |  | P |
---|---|---|---|---|---|
 |  |  | Positive | Negative |  |
 |  |  | n= 38 (44.2%) | n= 48 (55.8%) |  |
p53 | Negative | 29 (33.7) | 13 (34.2) | 16 (33.3) | 0.93 |
 | Positive | 57 (66.3) | 25 (65.8) | 32 (66.7) | |
p16 | Negative | 69 (80.2) | 27 (71.1) | 42 (87.5) | 0.057 |
 | Positive | 17 (19.8) | 11 (29.0) | 6 (12.5) | |
p27 | Negative | 37 (43.0) | 9 (23.7) | 28 (58.3) | 0.0013 |
 | Positive | 49 (57.0) | 29 (76.3) | 20 (41.7) | |
MDM2 | Negative | 66 (76.7) | 31 (81.6) | 35 (72.9) | 0.35 |
 | Positive | 20 (23.3) | 7 (18.4) | 13 (27.1) | |
Ki-67 | <30 | 43 (50.0) | 17 (44.7) | 26 (54.2) | 0.39 |
 | ≥30 | 43 (50.0) | 21 (55.3) | 22 (45.8) | |
EGFR | Negative | 46 (53.5) | 23 (60.5) | 23 (47.9) | 0.24 |
 | Positive | 40 (46.5) | 15 (39.5) | 25 (52.1) |  |